{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:25:43Z","timestamp":1792106743610,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To identify disease-specific cytokine and growth factor profile differences in the aqueous humor between wet age-related macular degeneration (AMD) patients and age-matched controls and to correlate their levels with the optical coherence tomography (OCT) findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Aqueous humors were obtained from 13 wet AMD eyes and 10 control eyes. Twenty cytokines and growth factors were measured using a RayBio antibody microarray technology in wet AMD and control eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The samples obtained from wet AMD patients exhibited a significantly increased expression of MCP-1, MIP-1\u03b1, MIP-1\u03b2, and vascular endothelial growth factor (VEGF). Subretinal fluid (SRF) patients showed significantly lower levels of proinflammatory cytokines, such as IL-1\u03b1 and GM-CSF, than those without SRF. Pigment epithelial detachments (PED) patients showed lower levels of inflammatory cytokines, such as GM-CSF, IFN-\u03b3, and TNF-\u03b1, than those without PED. Subretinal tissue (SRT) patients showed a higher level of IFN-\u03b3 than those without SRT. Compared with the controls, type 1 macular neovascularization (MNV) patients showed increased levels of MCP-1, MIP-1\u03b1, and MIP-1\u03b2, but not VEGF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.083). However, type 2 MNV patients showed increased levels of MCP-1 and VEGF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inflammatory cytokines varied according to the type of AMD- and OCT-based parameters. Our observation of low levels of VEGF in patients with type 1 MNV implies that the inhibition of VEGF alone appears to be insufficient treatment for these patients and that cytokines such as MCP-1, MIP-1\u03b1, and MIP-1\u03b2 should be modulated. And the presence of SRF in MNV may be associated with a positive prognosis because we found relatively low levels of proinflammatory cytokines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-021-02152-6","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:07:44Z","timestamp":1637237264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Jin-Ho","family":"Joo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woong","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"14","key":"2152_CR1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331.","journal-title":"N Engl J Med"},{"issue":"9","key":"2152_CR2","first-page":"1929","volume":"37","author":"A Kvanta","year":"1996","unstructured":"Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37(9):1929\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2152_CR3","first-page":"119","volume":"8","author":"HE Grossniklaus","year":"2002","unstructured":"Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119\u201326.","journal-title":"Mol Vis"},{"issue":"4","key":"2152_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581\u2013611.","journal-title":"Endocr Rev"},{"issue":"6","key":"2152_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/eye.2015.48","volume":"29","author":"WM Amoaku","year":"2015","unstructured":"Amoaku WM, Chakravarthy U, Gale R, Gavin M, Ghanchi F, Gibson J, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (London, England). 2015;29(6):721\u201331.","journal-title":"Eye (London, England)"},{"issue":"10","key":"2152_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","volume":"91","author":"A Lux","year":"2007","unstructured":"Lux A, Llacer H, Heussen FM, Joussen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol. 2007;91(10):1318\u201322.","journal-title":"Br J Ophthalmol"},{"key":"2152_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","volume":"50","author":"U Schmidt-Erfurth","year":"2016","unstructured":"Schmidt-Erfurth U, Waldstein SM. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res. 2016;50:1\u201324.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"2152_CR8","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.2337\/diacare.28.9.2252","volume":"28","author":"Y Katsura","year":"2005","unstructured":"Katsura Y, Okano T, Matsuno K, Osako M, Kure M, Watanabe T, et al. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care. 2005;28(9):2252\u20134.","journal-title":"Diabetes Care"},{"issue":"7252","key":"2152_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 2009;460(7252):225\u201330.","journal-title":"Nature"},{"issue":"10","key":"2152_CR10","first-page":"3649","volume":"35","author":"SG Robbins","year":"1994","unstructured":"Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci. 1994;35(10):3649\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2152_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.eye.6701438","volume":"19","author":"JB Jonas","year":"2005","unstructured":"Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye (London, England). 2005;19(2):163\u201370.","journal-title":"Eye (London, England)"},{"key":"2152_CR12","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol (Chicago, Ill : 1960). 1991;109(9):1242\u201357.","DOI":"10.1001\/archopht.1991.01080090066027"},{"issue":"10","key":"2152_CR13","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.ophtha.2014.04.020","volume":"121","author":"FA Folgar","year":"2014","unstructured":"Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121(10):1956\u201365.","journal-title":"Ophthalmology"},{"issue":"1","key":"2152_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe\u2019s Arch Clin Exp Ophthalmol. 2005;243(1):3\u20138.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2152_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (London, England). 2008;22(1):42\u20138.","journal-title":"Eye (London, England)"},{"issue":"2","key":"2152_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/1556-4029.14178","volume":"65","author":"DC Butler","year":"2020","unstructured":"Butler DC, Schandl C, Hyer M, Erin Presnell S. Aqueous fluid as a viable substitute for vitreous fluid in postmortem chemistry analysis. J Forensic Sci. 2020;65(2):508\u201312.","journal-title":"J Forensic Sci"},{"key":"2152_CR17","first-page":"772","volume":"13","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Kamei M, Itabe H, Yoneda K, Bando H, Kume N, et al. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis. 2007;13:772\u20138.","journal-title":"Mol Vis"},{"issue":"4","key":"2152_CR18","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1167\/iovs.06-1085","volume":"48","author":"K Yamada","year":"2007","unstructured":"Yamada K, Sakurai E, Itaya M, Yamasaki S, Ogura Y. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci. 2007;48(4):1839\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2152_CR19","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1167\/iovs.08-2495","volume":"50","author":"BA Austin","year":"2009","unstructured":"Austin BA, Liu B, Li Z, Nussenblatt RB. Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2009;50(6):2896\u2013902.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2152_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20071493","volume":"409","author":"M O'Hayre","year":"2008","unstructured":"O'Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J. 2008;409(3):635\u201349.","journal-title":"Biochem J"},{"issue":"8","key":"2152_CR21","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1167\/iovs.09-4605","volume":"51","author":"K Ishikawa","year":"2010","unstructured":"Ishikawa K, Yoshida S, Kadota K, Nakamura T, Niiro H, Arakawa S, et al. Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2010;51(8):4307\u201319.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2152_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1189\/jlb.0302117","volume":"73","author":"S Yoshida","year":"2003","unstructured":"Yoshida S, Yoshida A, Ishibashi T, Elner SG, Elner VM. Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol. 2003;73(1):137\u201344.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2152_CR23","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.168.5.2483","volume":"168","author":"EF Foxman","year":"2002","unstructured":"Foxman EF, Zhang M, Hurst SD, Muchamuel T, Shen D, Wawrousek EF, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol (Baltimore, Md : 1950). 2002;168(5):2483\u201392.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"1","key":"2152_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1167\/iovs.12-10602","volume":"54","author":"CA Wallace","year":"2013","unstructured":"Wallace CA, Moir G, Malone DF, Duncan L, Devarajan G, Crane IJ. Regulation of T-lymphocyte CCL3 and CCL4 production by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2013;54(1):722\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2152_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/ijms18030509","volume":"18","author":"Q Yang","year":"2017","unstructured":"Yang Q, Zhang Y, Liu X, Wang N, Song Z, Wu K. A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL\/6 and BALB\/c Mice. Int J Mol Sci. 2017;18(3):509.","journal-title":"Int J Mol Sci"},{"key":"2152_CR26","doi-asserted-by":"publisher","unstructured":"Wang C, Zhang R, Zhang Q, Jin H, Wei C, Wu C, et al. Cytokine profiles and the effect of intravitreal Aflibercept treatment on experimental choroidal neovascularization. Ophthalmic Res. 2020. https:\/\/doi.org\/10.1159\/000513588.","DOI":"10.1159\/000513588"},{"issue":"9","key":"2152_CR27","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"A Kauppinen","year":"2016","unstructured":"Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73(9):1765\u201386.","journal-title":"Cell Mol Life Sci"},{"key":"2152_CR28","first-page":"1","volume":"51","author":"CA Dinarello","year":"1992","unstructured":"Dinarello CA. The biology of interleukin-1. Chem Immunol. 1992;51:1\u201332.","journal-title":"Chem Immunol"},{"issue":"1","key":"2152_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/jop.2006.22.19","volume":"22","author":"Y Zou","year":"2006","unstructured":"Zou Y, Xu X, Chiou GC. Effect of interleukin-1 blockers, CK112, and CK116 on rat experimental choroidal neovascularization in vivo and endothelial cell cultures in vitro. J Ocul Pharmacol Ther. 2006;22(1):19\u201325.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"2152_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12886-018-1012-y","volume":"19","author":"W Lloyd Clark","year":"2019","unstructured":"Lloyd Clark W, Liu M, Kitchens J, Wang PW, Haskova Z. Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion. BMC Ophthalmol. 2019;19(1):11.","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"2152_CR31","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","volume":"122","author":"R Sophie","year":"2015","unstructured":"Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with Ranibizumab. Ophthalmology. 2015;122(7):1395\u2013401.","journal-title":"Ophthalmology"},{"issue":"6","key":"2152_CR32","doi-asserted-by":"publisher","first-page":"C1452","DOI":"10.1152\/ajpcell.00255.2009","volume":"297","author":"R Li","year":"2009","unstructured":"Li R, Maminishkis A, Banzon T, Wan Q, Jalickee S, Chen S, et al. IFN {gamma} regulates retinal pigment epithelial fluid transport. Am J Physiol Cell Physiol. 2009;297(6):C1452\u201365.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"2152_CR33","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1167\/iovs.08-1816","volume":"49","author":"G Shi","year":"2008","unstructured":"Shi G, Maminishkis A, Banzon T, Jalickee S, Li R, Hammer J, et al. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2008;49(10):4620\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2152_CR34","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1128\/MCB.19.6.4219","volume":"19","author":"P Sridhar","year":"1999","unstructured":"Sridhar P, Liu Y, Chin LD, Borja CE, Mann M, Skopicki HA, et al. Platelet-derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multiprotein complex. Mol Cell Biol. 1999;19(6):4219\u201330.","journal-title":"Mol Cell Biol"},{"key":"2152_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajo.2019.03.001","volume":"204","author":"A Invernizzi","year":"2019","unstructured":"Invernizzi A, Nguyen V, Teo K, Barthelmes D, Fung A, Vincent A, et al. Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the fight retinal blindness! Project. Am J Ophthalmol. 2019;204:105\u201312.","journal-title":"Am J Ophthalmol"},{"key":"2152_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.oret.2020.07.003","volume":"5","author":"NC Steinle","year":"2020","unstructured":"Steinle NC, Du W, Gibson A, Saroj N. Outcomes by baseline choroidal neovascularization features in age-related macular degeneration: a post hoc analysis of the VIEW studies. Ophthalmol Retina. 2020;5:141\u201350.","journal-title":"Ophthalmol Retina"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02152-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:10:16Z","timestamp":1637237416000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02152-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02152-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-691922\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current research followed the tenets of the Declaration of Helsinki, and all patients provided informed consent after an explanation of the study protocol. The Institutional Review Board at Kyung Hee University Hospital at Gangdong (KHNMC-2015-07-042) approved this prospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}